PHOENIX — Patients suffering with ALS now have a new ally in battling the debilitating disease.
After their son, Gregory, died from ALS in 2011, Ira and Mary Lou Fulton donated $2.7 million to the Barrow Neurological Institute to help create the Gregory W. Fulton ALS and Neuromuscular Disorders Center.
The 32,000 square-foot facility opened last December and “is expected to become a national leader in clinical research,” Dignity Health said in a press release.
According to Dr. Shafeeq Ladha, the center’s clinical director, the Fulton ALS Center will serve as a “one-stop shop for patients to receive all their ALS care.”
Care that includes clinical trials where researchers will directly interact with the patients and their families.
“We believe that we will be leaders in bringing new drugs to the forefront,” said Dr. Robert Bowser, director of the Fulton ALS Center. “Some of these will be tested for the first time ever on patients at our center.”
The center will also provide aid to those with muscular dystrophy and multiple sclerosis.
ALS, or amyotrophic lateral sclerosis, is also called Lou Gehrig’s disease, after the New York Yankees first baseman was diagnosed with it in 1939. It is a “progressive and neurodegenerative disease in which the cells that control voluntary muscle movements die, leading to paralysis and, ultimately death.”
The cause remains unknown and there is no cure.
- Skin Cancer in Arizona: Stats, facts and new immunotherapy drugs making strides
- Genetic testing could hold answers for colon cancer survival
- Breast cancer: Improved testing and treatments means more survivors
- Diet, exercise and aspirin: 3 tools to fight colon cancer
- The virus that keeps head and neck cancers on the rise
- 4 reasons cancer survivors should focus on food
- Common virus attributed to spike in head and neck cancers
- Today's radiation treatments offer better success, fewer side effects
- Navigating a new cancer survivorship plan
- Testing for genetic cancer is now more available in Phoenix